Ocular Therapeutix, Inc (OCUL) stock
OCULNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3011% above fair value
$6.02+0.01 (+0.17%)
Close on Nov 17, 2026Market cap $1.32BP/E –Yield –
Ocular Therapeutix market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Ocular Therapeutix's market cap was $1.46B on Nov 11, 2026, against $2.13B a year earlier. Over the last 5 years it ranged from $196.94M to $2.30B, with a median of $1.13B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.46B | -31.1% |
| 2025 | Dec 31, 2025 | $2.12B | +58.8% |
| 2024 | Dec 31, 2024 | $1.34B | +277.7% |
| 2023 | Dec 29, 2023 | $354.18M | +63.7% |
| 2022 | Dec 30, 2022 | $216.40M | -59.5% |
| 2021 | Dec 31, 2021 | $533.95M | -59.1% |
| 2020 | Dec 31, 2020 | $1.31B | +587.5% |
| 2019 | Dec 31, 2019 | $189.91M | +17.7% |
| 2018 | Dec 31, 2018 | $161.29M | +23.3% |
| 2017 | Dec 29, 2017 | $130.78M | -37.2% |
| 2016 | Dec 30, 2016 | $208.24M | -10.1% |
| 2015 | Dec 31, 2015 | $231.72M | -53.8% |
| 2014 | Dec 31, 2014 | $501.50M | – |
See a number that looks wrong?